Nothing Special   »   [go: up one dir, main page]

Ge et al., 2020 - Google Patents

FBXO22 degrades nuclear PTEN to promote tumorigenesis

Ge et al., 2020

View HTML @Full View
Document ID
15605987369175734431
Author
Ge M
Zhang N
Xia L
Zhang C
Dong S
Li Z
Ji Y
Zheng M
Sun J
Chen G
Shen S
Publication year
Publication venue
Nature Communications

External Links

Snippet

Nuclear localization of PTEN is essential for its tumor suppressive role, and loss of nuclear PTEN is more prominent than cytoplasmic PTEN in many kinds of cancers. However, nuclear PTEN-specific regulatory mechanisms were rarely reported. Based on the finding …
Continue reading at www.nature.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Hybridisation probes for diseases caused by alterations of genetic material for cancer

Similar Documents

Publication Publication Date Title
Ge et al. FBXO22 degrades nuclear PTEN to promote tumorigenesis
Bitler et al. ARID1A-mutated ovarian cancers depend on HDAC6 activity
Li et al. USP9X regulates centrosome duplication and promotes breast carcinogenesis
Du et al. The deubiquitylase OTUD3 stabilizes GRP78 and promotes lung tumorigenesis
Zhang et al. Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT–mTORC1 activation
Janouskova et al. Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors
Sun et al. Acetylation of Beclin 1 inhibits autophagosome maturation and promotes tumour growth
Park et al. PTEN self-regulates through USP11 via the PI3K-FOXO pathway to stabilize tumor suppression
Shi et al. A SIRT1-centered circuitry regulates breast cancer stemness and metastasis
Wozniak et al. PTEN is a protein phosphatase that targets active PTK6 and inhibits PTK6 oncogenic signaling in prostate cancer
Chowdhury et al. Multiple regulatory mechanisms of the biological function of NRF3 (NFE2L3) control cancer cell proliferation
Li et al. USP33 regulates centrosome biogenesis via deubiquitination of the centriolar protein CP110
Duan et al. FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas
Duan et al. Ubiquitin ligase RNF20/40 facilitates spindle assembly and promotes breast carcinogenesis through stabilizing motor protein Eg5
Xu et al. A signature motif in LIM proteins mediates binding to checkpoint proteins and increases tumour radiosensitivity
Hu et al. The USP10-HDAC6 axis confers cisplatin resistance in non-small cell lung cancer lacking wild-type p53
Borroni et al. Smurf2 regulates stability and the autophagic–lysosomal turnover of lamin A and its disease‐associated form progerin
Das et al. USP9X counteracts differential ubiquitination of NPHP5 by MARCH7 and BBS11 to regulate ciliogenesis
Yang et al. USP52 acts as a deubiquitinase and promotes histone chaperone ASF1A stabilization
Li et al. RNF167 activates mTORC1 and promotes tumorigenesis by targeting CASTOR1 for ubiquitination and degradation
Wang et al. Sirtuin5 protects colorectal cancer from DNA damage by keeping nucleotide availability
Choi et al. Programmed cell death 5 mediates HDAC3 decay to promote genotoxic stress response
Zhang et al. SMYD5 catalyzes histone H3 lysine 36 trimethylation at promoters
Yu et al. KMT5A-methylated SNIP1 promotes triple-negative breast cancer metastasis by activating YAP signaling
Wang et al. PRDX2 promotes the proliferation of colorectal cancer cells by increasing the ubiquitinated degradation of p53